![Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial]()
Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I TrialOliveira, G. A.; Wetzel, K.; Calvo-Calle, J. M.; Nussenzweig, R.; Schmidt, A.; Birkett, A.; Dubovsky, F.; Tierney, E.; Gleiter, C. H.; Boehmer, G.; Luty, A. J. F.; Ramharter, M.; Thornton, G. B.; Kremsner, P. G.; Nardin, E. H. · Infection and Immunity · 2005